ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02949128
Recruitment Status : Active, not recruiting
First Posted : October 31, 2016
Last Update Posted : July 27, 2018
Sponsor:
Information provided by (Responsible Party):
Alexion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 2018
  Estimated Study Completion Date : November 2020